Home » Pfizer Drug Promising in Midstage Psoriasis Study
Pfizer Drug Promising in Midstage Psoriasis Study
Pfizer Inc’s experimental drug tasocitinib showed promise in a mid-stage clinical trial for psoriasis, the drugmaker said on Thursday.
Finanz Nachrichten
Finanz Nachrichten
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May